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Morphine in Plasma and Cerebrospinal Fluid of Patients Addicted to Opiates 
Undergoing Surgery: High-performance Liquid Chromatography Method 
Mohammad Ali Haghbin MD1, Zia Navidi MD1, Cesar R. Romero-Leguizamon MD2,  
Mohammad Shabani PhD3 
 
Abstract 
Background: The prevalence of opium addiction among Iranians is considerable. Since endogenous opioid 
systems may be altered as a consequence of addiction, it is very important to determine the plasma and 
cerebrospinal fluid (CSF) levels of morphine in Iranian patients addicted to opiates who will undergo surgery. 
Methods: We obtained CSF and plasma samples from 50 volunteers with an established opioid addiction 
pattern. Samples were analyzed using high-performance liquid chromatography (HPLC). Additionally, 
frequency of nausea and vomiting, baseline heart rate (BHR), and systolic blood pressure (SBP) were 
recorded within the surgery and postoperatively during a 10-min interval. 
Findings: 84% of participants were men with a median age of 39.08 years. Mean score of body mass index 
(BMI) was 23.30 and most of the participants (46%) used opium in its traditional inhaled form. A higher 
concentration of morphine in blood was found in comparison with CSF (P < 0.001) in relation to the way of 
use. However, no statistically significant differences were found in relation to the type of addictive substance. 
No other association was found between the levels of morphine and the clinical characteristics of the 
patients. Moreover, results revealed no difference between hemodynamic-related data with blood and CSF 
level in opium-dependent patients. 
Conclusion: Quantification of plasma and CSF morphine, both immediately before initiation of surgery and 
subsequently on recovery room, showed that although clinical efficacy of systemic morphine was poor in 
addicted patients, it had no effect on patients’ hemodynamic variable and following complications after surgery. 
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Introduction 
Substance use disorder (SUD) is a pathological 
condition in which the use of one or more 
substances causes a clinically significant 
deterioration. According to the World Drug 
Report 2018, more than one quarter of billions of 
people in the world use drugs and 30.5 million of 
them suffer from SUD.1 Two important 
components of this disorder are dependence and 
addiction, the latter is a chronic neurobiological 
pathology with determinants related to genetic, 
biopsychosocial, and environmental elements.2 
Some of these patients may be dependent as a 
result of long-term pain therapy3 or opioid use 
disorder (OUD)4 which is characterized by 
behavior that includes one or more of the 
following: impaired control over drug use, 
compulsive consumption, continued use despite 
harm, and craving.5 In Europe, for instance, it has 
been approximately estimated from market 
surveillance data that there were around  
2.5 million strong opioid prescriptions in the 
primary care setting in 2004.6 Drug abuse and 
addiction in Iran are serious national problems.7 
The prevalence of opium addition in the Iranian is 
high, because Iran is a passage of drug and opiate 
trafficking from East Asia to Europe.8 Although 
addictive substances are excellent analgesics, they 
may affect a few functions such as those of 
respiratory and cardiovascular systems and 
induce gastrointestinal (GI) symptoms (ileus, 
nausea and vomiting, constipation).9 
Opium tolerance or dependence results from 
repeated exposure to an opioid substance causing 
a decreased analgesic effect through 
desensitization of antinociceptive mechanisms.10 
This generates a greater sensitivity to harmful 
stimuli, which shows that the constant 
administration of opioids activates the pain 
inhibitory systems as well as the pain facilitating 
systems.11 One of the most accepted hypotheses is 
that acute receptor desensitization by decoupling 
the G-protein-coupled receptor (GPCR) generates 
an up-regulation of cyclic adenosine  
3′,5′-monophosphate (cAMP) pathway, the 
subsequent activation of the N-methyl-D-aspartate 
(NMDA) receptor system, as well as the descending 
facilitation, which leads to an opioid-induced 
hyperalgesia.12 Another molecular mechanism 
studied in this process is the mammalian target of 
rapamycin (mTOR), an important axis of other 
central nervous system (CNS) disorders such as 
epilepsy,13 which has been associated with chronic 
pain states and their relationship with opioid-
induced tolerance/hyperalgesia.14 
For opium-dependent patients after surgery, 
treatment options involve further up-titration of 
the current opioid regimen, the addition of 
adjunctive agents with different mechanisms of 
pain control in a multimodal approach, and 
attempting an opioid switch or crop rotation to a 
different opioid analgesic; which all have further 
subsequent complications.15 
Another aspect to keep in mind is that 
endogenous opioid systems may be altered as a 
consequence of addiction.16 Although there has 
been considerable progress in understanding the 
distribution, biosynthesis, and physiology of 
endogenous opioids, it is not yet clear how they 
are affected by tolerance and dependence in 
patients who need surgery. There are some 
examples of how these systems are altered in 
animal models,17 but this becomes more 
important considering that patients receiving 
long-term opioid treatment are more likely to 
require surgery and higher doses of opioids after 
the operation.18,19 
For all the above, it is important to determine 
cerebrospinal fluid (CSF) and serum morphine 
concentration in opium addict patients that 
undergo surgery. 
Methods 
This was a cross-sectional study with approval of 
the Ethics Committee of Kerman University of 
Medical Sciences, Kerman, Iran. We studied 
opiate-addicted patients who were scheduled for 
surgery. All the volunteer patients were classified 
as status II according to the American Society of 
Anesthesiologists (ASA) physical status 
classification system.  
Inclusion and exclusion criteria: Inclusion 
criteria consisted of all patients admitted for spinal 
anesthesia and further surgery who were claimed to 
be opium-dependent in the previous year. 
Patients were excluded from the study when: 
1. being younger than 20 or older than 60 years 
old, 2. having chronic inflammatory disease, 
hypertension, diabetes, obesity, and liver or renal 
disease, 3. taking regularly nonsteroidal anti-
inflammatory drugs (NSAIDs), 4. having medical 
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history of drug or alcohol abuse and psychiatric 
disorder, 5. having any contraindications for 
spinal anesthesia, 6. multiple trauma, or 7. 
intravenous (IV) administration of morphine. 
Lumbar puncture procedure: Blood sample was 
obtained 5 minutes before induction of anesthesia. 
CSF was acquired within the surgery by lumbar 
puncture with the patient in the lateral decubitus 
position. A 22-gauge spinal needle was inserted 
into the L3-L4 interspace. After local anesthesia 
(lidocaine 2%), 1 ml of CSF was collected and 
subsequently transported under standard 
conditions to the clinical laboratory, where they 
were centrifuged in a refrigerated centrifuge. All 
samples (serum and CSF) were analyzed by high-
performance liquid chromatography (HPLC) with 
2000 ng Pirates Cobas Integra kits.  
Baseline heart rate (BHR), systolic blood 
pressure (SBP), and nausea and vomiting were 
recorded within the surgery and postoperatively 
during a 10-min interval. Patient’s characteristic 
information was gathered and data analysis was 
done using SPSS software (version 21, IBM 
Corporation, Armonk, NY, USA). Data were 
expressed as mean ± standard deviation (SD) 
(Tables) and mean ± standard error (SE) (Figure) 
for quantitative variables, and number and 
percentage for qualitative ones. Analysis of 
variance (ANOVA) and Pearson tests were used 
when appropriate, and P < 0.050 was considered 
as statistically significant. The statistical 
relationships between the serum and CSF level of 
morphine and the study variables were evaluated 
using a Pearson correlation analysis. 
Results 
100 patients with scheduled surgery requiring 
hospital admission and spinal anesthesia were 
enrolled in our study. No patients entered in the 
study were excluded from the primary analysis. 
The median age of participants was 39.08 years 
and about 84% of participants were men. Mean 
score of body mass index (BMI) was 23.30 and 
most of them (46%) used opium in its traditional 
inhaled form (Table 1).  
There were no significant differences in terms 
of BMI, sex, type and form of opium abuse, length 
of addiction, and number of surgical spine levels 
with serum-spinal morphine concentrations in all 
time points (P > 0.050) (Tables 2 and 3). Age was 
the only correlated variable with serum morphine 
level (P = 0.030). Older patients had a higher level 
of morphine in their blood; it might show lower 
dose requirement on elderly people.  
Analyzing patients hemodynamic monitoring 
[set by the values of heart rate (HR), as well as 
SBP and diastolic blood pressure (DBP)] data 
inter- and post-operatively showed that there was 
no relationship between them and plasma and 
CSF levels (Tables 4 and 5).  
 
Table 1. Demographic variables of participants 
Variable Value P (serum) P (CSF) 
Sex [n (%)] Men 42 (84) 0.630 0.130 
Women 8 (16) 
Marital status [n (%)] Married 43 (86) - - 
Single 7 (14) 
Form of abuse [n (%)] Oral 24 (48) - - 
Inhalation 23 (46) 
Both 3 (6) 
Substance type [n (%)] Opium 42 (84) 0.770 0.600 
Thick opium 14 (28) 
Heroin 4 (8) 
Methadone 11 (22) 
Age (year) (mean ± SD) 39.08 ± 11.90 0.001 0.270 
Weight (kg) (mean ± SD) 66.92 ± 13.02 - - 
Height (cm) (mean ± SD) 169.30 ± 5.94 - - 
BMI (kg/m2) (mean ± SD) 23.30 ± 4.07 - - 
Years of addiction (mean ± SD) 11.32 ± 8.56 0.370 0.130 
Last consumption hours (mean ± SD) 24.62 ± 2.94 - - 
P-value less than 0.050 is considered significant. 
CSF: Cerebrospinal fluid; BMI: Body mass index; SD: Standard deviation 
Morphine CSF and Plasma Concentrations in Surgery Haghbin et al. 
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Table 2. Plasma and cerebrospinal fluid (CSF) morphine levels based on the form of opium abuse 
Morphine concentration  Both form 
(mean ± SD) 
Inhalation 
(mean ± SD) 
Oral  
(mean ± SD) 
P  
(ANOVA test) 
Blood 382.66 ± 249.71 682.21 ± 127.96 799.79 ± 124.22 0.700 
CSF 99.00 ± 26.00 71.56 ± 18.95 109.27 ± 33.23 0.600 
P-value less than 0.050 is considered significant.  
CSF: Cerebrospinal fluid 
 
Table 3. Pearson correlation analysis of body mass 
index (BMI), consumption time, age, sex, and 
morphine levels  
Variable CSF Blood 
r P r P 
BMI 0.099 0.495 -0.007 () 0.960 
Consumption 
time 
0.217 0.130 -0.296 0.037 
Age 0.157 0.275 0.307 0.030 
Sex (Men) 0.216 0.133 0.635 0.069 
Sex (Women) -0.49 0.754 0.081 0.318 
r: Pearson correlation coefficient; CSF: Cerebrospinal fluid; 
BMI: Body mass index 
 
There was a 8.2 folds difference between 
serum morphine and CSF morphine levels. These 
data were gathered in 10-minute interval; the only 
statistically significant time point was 10 minutes 
after patients’ entrance to recovery (P = 0.001). In 
addition, there was no relationship between 
serum-CSF level with post-operation nausea and 
vomiting (Table 6). The results showed that the 
CSF morphine level of addicted patients in all 
forms of opium abuse (oral and inhalation) was 
statistically less than the serum level (P < 0.001) 
(Figure 1). 
Discussion 
Some patients who are going to undergo 
anesthesia for a surgery may be either opioid 
dependent or tolerant to opioid analgesic 
drugs.20,21 For those doctors who care for opiate-
dependent patients in the postoperative 
environment, this situation is a great challenge 
and also for the anesthesiologists equally; 
however, there is little attention drown to the 
other complications like nausea, vomiting, and 
hemodynamic instability. This problem is based 
on the difficulty to find the perfect balance 
between a useful medication for pain 
management and the risk that exists due to 
adverse reactions or the development of 
addiction,22 thus raising significant ethical 
concerns.23,24 
 
 
Figure 1. A decreased cerebrospinal fluid (CSF) 
morphine concentration was observed in all forms of 
opium abuse compared to the blood morphine level. 
*P < 0.001 compared to the blood level 
Data are presented as mean ± standard error of the mean (SEM). 
 
Table 4. Pearson correlation analysis of systolic and diastolic blood pressures (DBP) and morphine levels  
Measurement time (minute) SBP DBP 
CSF Blood CSF Blood 
r P r P r P r P 
Base line -0.048 0.740 -0.106 0.465 0.071 0.625 0.040 0.784 
10 0.784 0.001 0.263 0.065 -0.044 0.763 -0.102 0.479 
20 -0.102 0.490 0.183 0.213 0.026 0.862 -0.007 0.963 
30 -0.159 0.368 -0.187 0.290 -0.074 0.676 -0.068 0.704 
40 0.033 0.914 -0.227 0.457 0.464 0.110 0.602 0.300 
50 0.846 0.034 0.346 0.502 0.211 0.688 0.315 0.543 
60 0.939 0.061 0.296 0.704 -0.014 0.986 0.590 0.410 
r = Pearson correlation coefficient 
SBP: Systolic blood pressure; DBP: Diastolic blood pressure; CSF: Cerebrospinal fluid  
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Table 5. Pearson correlation analysis of heart rate 
(HR) and morphine levels 
Measurement 
time (minute) 
CSF Blood 
r P r P 
Base line 0.136 0.347 0.226 0.114 
10  0.076 0.599 0.104 0.473 
20  0.060 0.687 0.107 0.469 
30 0.138 0.436 0.122 0.492 
40  0.074 0.810 0.323 0.282 
50  -0.330 0.523 0.189 0.720 
60  0.486 0.514 0.970 0.300 
r = Pearson correlation coefficient; CSF: Cerebrospinal fluid 
 
The assays were performed on these  
100 patients with a frequent prevalence of opium 
abuse and results showed that opioid-dependent 
patients had significantly higher mean plasma 
and CSF morphine levels than the normal.  
 
Table 6. Pearson correlation analysis of nausea and 
morphine levels during surgery and recovery  
Measurement 
time (minute) 
CSF Blood 
r P r P 
Base line 0.072 0.622 0.139 0.336 
10  0.077 0.594 0.033 0.818 
20  0.099 0.495 0.026 0.856 
30 0.100 0.489 -0.029 0.844 
40 0.023 0.872 -0.171 0.234 
50  0.086 0.580 -0.049 0.754 
60  0.380 0.847 -0.051 0.795 
70  0.256 0.322 -0.127 0.627 
80  0.195 0.544 0.149 0.644 
90  -0.132 0.716 -0.204 0.572 
100  -0.889 0.111 -0.191 0.809 
r = Pearson correlation coefficient; CSF: Cerebrospinal fluid 
 
In contrast, O’Brien et al. have shown that some 
morphine metabolites in CSF like 6-endorphin 
levels were significantly lower in addicted patients 
as compared to the healthy people.25 Addiction is a 
pathological condition in which the balance of the 
endogenous opioids of the human body is altered. 
Although the large number of variables and small 
sample sizes involved make interpretation of the 
data difficult, one reason for this controversy may 
be related to differences between normal people 
and addicts in sex ratio, race, and ethnic 
background in O’Brien et al. study which were not 
consistent with our results. 
In some aspects, a particular part of the results 
are relevant in that opioid intake with changes in 
serum opioid and CSF levels could not change 
hemodynamic variables during surgery. 
Anesthesiologists are probable to deal with a 
variety of opioid-dependent patients. An element 
to consider in order to prevent tolerance or the 
development of addiction, is to pay attention to 
the increase in the requirement of the doses 
used,26 and more complications is expected. 
Nugent et al. evaluated transdermal fentanyl dose 
escalation in 73 patients with pain related to 
terminal malignancy. They disclosed that the 
initial fentanyl dose of 75 µg per hour became 
greater than 25% to a final median dose of  
100 microgram per hour in addicted patients.27 
Our study limitation was scarce information 
about patient opium dosage and frequency 
because it is known as a shame for Iranian and 
addiction is not still well understood as a 
behavioral disorder. 
Conclusion 
Measuring plasma and CSF morphine in different 
time intervals both at once before beginning of the 
surgery and then on recovery room showed that 
although clinical efficacy of systemic morphine 
was poor in addicted patients, it did not affect 
patients’ hemodynamic variable and following 
complications after surgery. 
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 لاعما در مخدر معتاد به مواد بیماران در مورفین نخاعی -مغزی مایع و پلاسمایی سطح
 بالا ییبا کارا عیما یکروماتوگرافاستفاده از روش  جراحی:
 
 3دکتر محمد شعبانی، 2یزامونلگو ، دکتر سزار آر رومرو1، دکتر ضیاء نویدی1بیندکتر محمد علی حق
 
 
 چکیده
خدر تغییر د به مواد مب اعتیاجا که فعالیت سیستم اپیوئیدی اندوژن به سبباشد و از آنشیوع اعتیاد به مواد مخدر در ایران قابل توجه می مقدمه:
جربه خواهند حاد را تخاعی مورفین در بیماران تحت عمل جراحی به علت این که به زودی درد ن -کند، بررسی سطوح پلاسمایی و مایع مغزیمی
 .ای داردکرد، اهمیت ویژه
یاک با استفاده از روش تر به معتادان نخاعی -مغزی نمونه از مایع 05و  پلاسمایی نمونه 05مطالعه حاضر، میزان مورفین در  در ها:روش
ربان قلب پایه، ضسنجش قرار گرفت. میزان ) مورد CLPHیا  yhpargotamorhc diuqil ycneiciffe hgiH( بالا ییبا کارا عیما یکروماتوگراف
 .ردیددقیقه ثبت گ 01فشار خون سیستولیک و شیوع تهوع و استفراغ طی عمل جراحی و پس از عمل در ریکاوری با فاصله زمانی 
تریاک را به فرم استنشاقی  بیماراندرصد را زنان تشکیل دادند.  61ها را مردان و درصد آن 48سال بود که  93/80میانگین سنی بیماران  ها:یافته
 سه فرم خوراکی، نخاعی در هر -کردند. سطح مورفین مایع مغزیدرصد)، خوراکی و یا هر دو شکل استفاده می 64(بیشترین فرم مصرف: 
ر با سطح افیک بیماهای دموگرداری بین ویژگی). ارتباط معنیP > 0/100ستنشاقی کمتر از سطح پلاسمایی آن بود (ا -استنشاقی و خوراکی
ن ریاک با میزاداری بین تغییرات همودینامیک بیماران معتاد به تخاعی مشاهده نشد. همچنین، رابطه معنین -مورفین پلاسمایی و مایع مغزی
 .نخاعی وجود نداشت -مورفین خون و مایع مغزی
دهد که با وجود می بیماران معتاد قبل و بعد از شروع جراحی و ریکاوری نشانخاعی در ن -گیری کمی مورفین پلاسما و مایع مغزیاندازه گیری:نتیجه
 .گیردمیقرار ن کاهش اثرات کلینیکی مصرف سیستمیک مورفین، متغیرهای همودینامیک بیماران در حین عمل و پس از عمل جراحی تحت تأثیر
 از عمل خاعی، اعتیاد به تریاک، درد پسن -مورفین، مایع مغزی واژگان کلیدی:
معتاد  انبیمار در مورفین اعینخ -مغزی مایع و پلاسمایی سطح .، شعبانی محمدسزار آر زامونیلگو بین محمد علی، نویدی ضیاء، رومروحق ارجاع:
 .59-101: )2( 01؛7931 مجله اعتیاد و سلامت .بالا ییبا کارا عیما یکروماتوگرافاستفاده از روش  جراحی: اعمال در مخدر به مواد
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